Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
548.69B
Market cap548.69B
Price-Earnings ratio
20.34
Price-Earnings ratio20.34
Dividend yield
2.29%
Dividend yield2.29%
Average volume
10.33M
Average volume10.33M
High today
$228.68
High today$228.68
Low today
$224.90
Low today$224.90
Open price
$226.39
Open price$226.39
Volume
9.03M
Volume9.03M
52 Week high
$228.68
52 Week high$228.68
52 Week low
$141.50
52 Week low$141.50

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $228.19. The company's market cap stands at 548.69B, with a P/E ratio of 20.34 and a dividend yield of 2.3%.

On 2026-01-28, Johnson & Johnson(JNJ) stock traded between a low of $224.90 and a high of $228.68. Shares are currently priced at $228.19, which is +1.5% above the low and -0.2% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 9.03M, against a daily average of 10.33M.

During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $228.68 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $228.68 at its peak.

JNJ News

TipRanks 15m
Top Johnson & Johnson Insider Makes a Blockbuster Move With Company Stock

New insider activity at Johnson & Johnson ( (JNJ) ) has taken place on January 28, 2026. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerfu...

Investing.com 3h
Duato, Johnson & Johnson CEO, sells $22.1 million in JNJ stock - Investing.com

...

Duato, Johnson & Johnson CEO, sells $22.1 million in JNJ stock - Investing.com
Nasdaq 8h
Dividend Growers: 2 Stocks That Could Be Worth $1 Trillion in 7 Years

Key Points Visa's terrific business should help support its dividend program. Johnson & Johnson has over 50 years of consecutive dividend growth. 10 stocks w...

Dividend Growers: 2 Stocks That Could Be Worth $1 Trillion in 7 Years

Analyst ratings

56%

of 27 ratings
Buy
55.6%
Hold
37%
Sell
7.4%

More JNJ News

TipRanks 16h
Johnson & Johnson upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley upgraded Johnson & Johnson to Overweight from Equal Weight with a price target of $262, up from $200. The firm cites its higher estimates from th...

Simply Wall St 21h
Johnson & Johnson Oncology Advances Inform Multiple Myeloma Growth Outlook

FDA approved a new DARZALEX FASPRO combination regimen for newly diagnosed multiple myeloma patients who are not eligible for stem cell transplant, marking the...

Johnson & Johnson Oncology Advances Inform Multiple Myeloma Growth Outlook
TipRanks 1d
J&J confirms FDA approves quadruplet regimen for multiple myeloma

Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration approved Darzalex Faspro in combination with bortezomib, lenalidomide and dex...

Nasdaq 1d
Dow Analyst Moves: JNJ

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnso...

Dow Analyst Moves: JNJ
Nasdaq 2d
Johnson & Johnson a Top Ranked SAFE Dividend Stock With 2.4% Yield

Johnson & Johnson (Symbol: JNJ) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-averagestatistics including a strong...

Johnson & Johnson a Top Ranked SAFE Dividend Stock With 2.4% Yield
Simply Wall St 4d
How J&J’s 2026 Sales and EPS Outlook At Johnson & Johnson Has Changed Its Investment Story

Earlier this week, Johnson & Johnson reported fourth-quarter 2025 and full-year results showing sales of US$24.56 billion for the quarter and US$94.19 billion f...

How J&J’s 2026 Sales and EPS Outlook At Johnson & Johnson Has Changed Its Investment Story
TipRanks 6d
Top 3 Stocks to Watch Right Now, According to AI Analyst, 1/23/2026

The TipRanks AI Analyst tool scans analyst ratings, price targets, and market trends to highlight stocks with strong upside potential. Using TipRanks’ AI Analys...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.